English
Home > Products > PropylsulfaMide

China PropylsulfaMide Factory

Our growth depends on the superior equipment ,exceptional talents and continuously strengthened technology forces for PropylsulfaMide,CAS NO 147962-41-2,147962-41-2,Macitentan intermediate,Macitentan advance intermediate, We're on the lookout ahead to building positive and effective links while using the providers around the environment. We warmly welcome you to definitely get hold of us to begin discussions on how we will bring this into being.
PropylsulfaMide, We accomplish this by exporting our wigs directly from our own factory to you. The goal of our company is to get customers who enjoy coming back to their business. We sincerely hope to cooperate with you in the near future. If there's any opportunity, welcome to visit our factory!!!

Related Products

Hot Products

  • 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline

    4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline

    Product Name:4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
    Molecular Formula:C14H17ClN2O4
    Molecular Weight:312.75
    CAS Registry Number:183322-18-1
  • BenzenaMine, 2-broMo-5-fluoro-4-nitro-

    BenzenaMine, 2-broMo-5-fluoro-4-nitro-

    Product Name:BenzenaMine, 2-broMo-5-fluoro-4-nitro-
    Molecular Formula:C6H4BrFN2O2
    Molecular Weight:235.01
    CAS Registry Number:952664-69-6
  • Docetaxel Impurity SDH

    Docetaxel Impurity SDH

    Product Name:Docetaxel Impurity SDH
    Molecular Formula:C51H59NO15
    Molecular Weight:926.01
    CAS Registry Number:1354900-65-4
  • Perfluorotripropylamine

    Perfluorotripropylamine

    Product Name:Perfluorotripropylamine
    Molecular Formula:C9F21N
    Molecular Weight:521.07
    CAS Registry Number:338-83-0
  • Rifamycin S

    Rifamycin S

    Product Name:Rifamycin S
    Molecular Formula:C37H45NO12
    Molecular Weight;695.75
    CAS Registry Number;13553-79-2
  • Paliperidone

    Paliperidone

    Product Name:Paliperidone
    Molecular Formula:C23H27FN4O3
    Molecular Weight;426.48
    CAS Registry Number;144598-75-4
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept